Change in Eosinophil Count in Patients with Heart Failure Treated with Anakinra

Change in Eosinophil Count in Patients with Heart Failure Treated with Anakinra

Background: Interleukin-1 blockade with anakinra leads to a transient increase in eosinophil blood count (eosinophils) in patients with acute myocardial infarction. We aimed to investigate the effect of anakinra on changes in eosinophils in patients with heart failure (HF) and their correlation with...

Full description

Bibliographic Details
Main Authors: Michele Golino, Francesco Moroni, Marco Giuseppe Del Buono, Justin M. Canada, Azita H. Talasaz, Sebastian Piñel, James Mbualungu, Alessandra Vecchiè, Ai-Chen (Jane) Ho, Georgia K. Thomas, Salvatore Carbone, Hayley E. Billingsley, Jeremy Turlington, Roshanak Markley, Cory Trankle, Roberto De Ponti, Benjamin Van Tassell, Antonio Abbate
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Cells
Subjects:
eosinophils
heart failure
interleukin-1
interleukin-1 receptor antagonist protein
injection site reaction
cardiorespiratory fitness
Online Access:https://www.mdpi.com/2073-4409/12/8/1129

Internet

https://www.mdpi.com/2073-4409/12/8/1129

Similar Items